{
  "id": 18375969,
  "title": "Engineered protein that cuts Alzheimer's-linked brain deposits opens potential therapeutic avenue",
  "url": "https://urgent.news/2026/11/05/engineered-protein-that-cuts-alzheimers-linked-brain-deposits-opens",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-11-05T21:20:02.000Z",
  "source": {
    "name": "Medical Xpress",
    "slug": "medical-xpress",
    "url": "https://medicalxpress.com/news/2026-11-protein-alzheimer-linked-brain-deposits.html"
  },
  "original_language": "en",
  "account": "A KAIST-led research team has discovered that a zinc finger protein can suppress the formation of harmful amyloid-beta protein deposits in the brains of Alzheimer's disease patients. Amyloid-beta is a peptide associated with the disease, and its aggregation can damage nerve cells. The treatment also reduced the toxicity of existing amyloid-beta aggregates. The researchers identified a specific segment of the zinc finger protein, named ZF2–4, that binds directly to regions of amyloid-beta involved in its aggregation. By binding to these regions, ZF2–4 altered the aggregation of amyloid-beta, suppressing the formation of long, entangled toxic fibrils and reducing the toxicity of existing fibrils. The team also developed a method for delivering the protein to the brain by attaching a short peptide to the protein, creating a brain-penetrant variant. When administered to a mouse model of Alzheimer's disease, this variant reduced amyloid-beta deposits in the cerebral cortex and hippocampus by about 53%, improving recognition memory in the mice. However, no significant improvements were observed in other memory and learning tests. While these results provide a promising avenue for developing protein-based therapeutics that target amyloid-beta, further studies are needed to evaluate the therapeutic efficacy and long-term safety of this approach before it can be applied to humans.",
  "summary": "A KAIST-led research team has found that a protein involved in gene regulation can suppress the harmful aggregation of amyloid-beta, a peptide associated with Alzheimer's disease. The approach also reduced the toxicity of protein aggregates that had already formed.",
  "key_points": [
    "KAIST researchers discover zinc finger protein that cuts Alzheimer's-linked amyloid-beta deposits",
    "ZF2–4 segment of protein binds to amyloid-beta regions involved in aggregation",
    "Brain-penetrant variant reduces amyloid-beta deposits by 53% in mouse model"
  ],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}